NuScale Power (NYSE: SMR) is currently trading at just under $8 per share, a steep fall from its all-time high of $53 reached during peak investor enthusiasm for nuclear energy stocks.

Over the past three years, the stock has swung dramatically between $2 and $53, with five separate drawdowns of 50% or more recorded across that period.

The current decline stands as the worst of those drawdowns, with the stock losing roughly 85% from its peak, representing one of the more punishing collapses among nuclear sector names.

Critically, that decline was not triggered by a specific corporate disaster or fundamental business failure, but rather by a broader retreat in investor sentiment toward nuclear power stocks.

NuScale Power is developing small modular nuclear reactors, a technology widely considered a potential game changer for the energy industry due to its factory-built design and scalable deployment model.

SMRs are seen as potentially less costly, safer, and easier to site near population and industrial centers compared to the large-scale conventional reactors that currently dominate the nuclear landscape.

The company holds an approved reactor design, which represents a significant regulatory milestone, but it has not yet built or sold its first commercial SMR to any customer.

NuScale has been in advanced discussions with Romanian power company RoPower, which has approved a project involving six NuScale SMRs, though project financing has not yet been secured.

The company is also engaged with ENTRA1 Energy and the Tennessee Valley Authority in connection with what has been described as potentially “the largest nuclear power deployment program in U.S. history.”

Analysts and investors broadly agree that a signed commercial contract for its first SMR sale is the catalyst most likely to drive a meaningful re-rating of the stock, potentially pushing it back toward the $20 level.

Even a first contract, however, would mark only the beginning of the next phase of NuScale’s development, as the company would still need to demonstrate it can construct, operate, and reliably deliver its reactor technology at commercial scale.

NuScale remains a high-risk early-stage company, and that fundamental risk profile is unlikely to change materially until it moves beyond the development stage and into proven commercial operation.